drugset

drugset / Trial / NCT01201187

Efficacy and Safety Study of Combination of Ginkgo Extract and Ginseng Extract(YY-162)in Children With ADHD

NCT01201187 ↗

Phase 3 Completed 144 enrolled Yuyu Pharma, Inc.

RandomizedParallel-groupDouble-blindTreatment

Summary

This study will evaluate clinical efficacy and safety of treatment with YY-162 in children with ADHD

Timeline

Start: 2010-03
Primary completion: 2010-04
Completion: 2011-04

Publications

Results Lyon MR, Cline JC, Totosy de Zepetnek J, Shan JJ, Pang P, Benishin C. Effect of the herbal extract combination Panax quinquefolium and Ginkgo biloba on attention-deficit hyperactivity disorder: a pilot study. J Psychiatry Neurosci. 2001 May;26(3):221-8.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	YY-162	Traditional medicine (herbal / TCM)	—	Oral

Indications